ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors. To view the Presentation, please visit:
https://abnnewswire.net/lnk/20846ZE6
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
Contact
Steven LydeamoreCEO, Anatara Lifesciences Ltd
+61 (0) 438 027 172
slydeamore@anatara.com
Eric Kuret
Market Eye
+61 (0) 417 311 335
eric.kuret@marketeye.com.au
Related Companies
